Genelux (GNLX) Interest Coverage Ratio (2022 - 2026)
Genelux (GNLX) posted quarterly Interest Coverage Ratio of 27.29 for Q1 2026, up 71.71% year-over-year from 15.9 in Q1 2025, and down 1600.26% quarter-over-quarter from 1.61 in Q4 2025.
Genelux (GNLX) Interest Coverage Ratio (2022 - 2026) Analysis & Trends
Genelux's Interest Coverage Ratio history runs 5 years deep, the most recent figure standing at 27.29 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 71.71% year-over-year to 27.29; the TTM figure through Mar 2026 stood at 102.88 (down 164.88% YoY), while the FY2025 annual figure was 0.42, up 18.97% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 27.29, down from 1.61 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 162.84 in Q4 2022, with the low at 96.49 in Q1 2025.
- The 5-year median for Interest Coverage Ratio is 1.84 (2023), against an average of 8.8.
- Peak annual rise in Interest Coverage Ratio reached 468.02% in 2024, while the deepest fall reached 57072.15% in 2024.
- Genelux's Interest Coverage Ratio stood at 162.84 in 2022, then plunged by 88.02% to 19.5 in 2023, then soared by 468.02% to 110.77 in 2024, then plunged by 101.45% to 1.61 in 2025, then sank by 1600.26% to 27.29 in 2026.
- Business Quant data shows GNLX's Interest Coverage Ratio at 27.29 in Q1 2026, 1.61 in Q4 2025, and 2.51 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Genelux | 119.87 Mn | 119.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.29 |
| Dec 31, 2025 | -1.61 |
| Sep 30, 2025 | -2.51 |
| Jun 30, 2025 | -15.81 |
| Mar 31, 2025 | -96.49 |
| Dec 31, 2024 | 110.77 |
| Sep 30, 2024 | -41.32 |
| Mar 31, 2024 | -4.93 |
| Dec 31, 2023 | 19.50 |
| Sep 30, 2023 | -0.07 |
| Jun 30, 2023 | -0.05 |
| Mar 31, 2023 | -2.08 |
| Dec 31, 2022 | 162.84 |
| Sep 30, 2022 | 22.18 |